Journal
MOLECULES
Volume 22, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/molecules22060939
Keywords
pharmacokinetics; tissue distribution; indirect competitive enzyme-linked immunosorbent assay; puerarin
Funding
- National Natural Science Foundation of China [81274043, 81473338, 81503344]
- Young Teacher Special Projects of Beijing University of Chinese Medicine [2015-JYB-JSMS014]
- Classical Prescription Basic Research Team of Beijing University of Chinese Medicine
Ask authors/readers for more resources
Puerarin (PUE) is a compound isolated from the roots of Pueraria lobata. We studied the pharmacokinetics and tissue distribution kinetics of PUE in Sprague-Dawley rats following intraperitoneal administration of three concentrations. Indirect competitive ELISA based on an anti-PUE monoclonal antibody was used to determine the concentration of PUE in the blood, heart, liver, spleen, lung, kidney, hippocampus, cerebral cortex, and striatum. The plasma and tissue distribution kinetic characteristics following a single injection of PUE (20, 40 and 80 mg/kg) were calculated using a non-compartment model. In the high-dose (80 mg/kg) and medium-dose (40 mg/kg) groups, the kinetic profile of PUE in blood and kidney samples showed two absorption peaks, while that of the other tissues showed only one peak. In the low-dose (20 mg/kg) group, there was only one peak, irrespective of the sample type. Pharmacokinetic parameters, such as the area under the curve, C-max, and T-max varied according to the administered dose. AUC and C-max values increased dose-dependently. PUE was widely distributed in areas of the brain such as the hippocampus, cerebral cortex, and striatum, providing a foundation for guiding the use of PUE in the treatment of cerebral ischaemic stroke and neurodegenerative diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available